PharmaCyte Biotech Inc (PMCB)

[1234jklm]

And this time they can keep giving doses

Last clinical trials were limited to a couple of doses because of the time it took to prove the cells were sterile. So cell life back then was much shorter.

Now they can grow cells reliably and freeze them so it's a much longer time span. Hence more doses can be given

And

The imaging being used this time is much more accurate.

And
'
This time they have a better choice of seeding cells to create the banks.

Two very important extra reasons why it should bring vastly improved results this time.

Is it perhaps why the more recent ascites trials resulted in complete tumor regression?